You just read:

U.S. FDA Approves INVOKAMET® XR (Canagliflozin / Metformin Hydrochloride Extended-Release) for the Treatment of Adults with Type 2 Diabetes

News provided by

Janssen Pharmaceuticals, Inc.

Sep 21, 2016, 08:00 ET